| Literature DB >> 34950566 |
Shin Koike1, Shotaro Nakanishi1, Sunao Nohara1, Hirofumi Miyahira2, Tomoko Tamaki2, Seiichi Saito1.
Abstract
Large adrenocortical adenomas have rarely been reported. We describe a case of a 26-year-old man who underwent an adrenalectomy for a large adrenocortical adenoma (8.6 × 7.7 cm). Although the lesion had typical malignant features on imaging, histopathological examination revealed an adrenocortical adenoma. This highlights that imaging alone may not be able to distinguish adrenocortical carcinomas from adrenal masses. In most cases, a resection should be performed for early diagnosis and management of large adrenal masses with malignant features on imaging. To our knowledge, this is the first report of a large adrenocortical adenoma diagnosed with multiple imaging investigations.Entities:
Keywords: 18F-FDG PET/CT, F-18 fluorodeoxyglucose positron emission tomography/computed tomography; Adrenal incidentaloma; Adrenal mass; Adrenocortical adenoma; Adrenocortical carcinoma; CT, computed tomography; MRI, magnetic resonance imaging; SUVmax, maximum standardized uptake value
Year: 2021 PMID: 34950566 PMCID: PMC8671860 DOI: 10.1016/j.eucr.2021.101968
Source DB: PubMed Journal: Urol Case Rep ISSN: 2214-4420
Fig. 1Radiologic findings. (a, b) Contrast-enhanced computed tomography revealing an 8.6 × 7.7-cm heterogeneously enhancing left suprarenal mass with increased vascularity. (c) T2-weighted magnetic resonance imaging showing a hyperintense left adrenal mass.
Fig. 2Imaging findings. (a) 123I-meta-iodobenzylguanidine scintigraphy showing no signs of a pheochromocytoma. (b, c) F-18 fluorodeoxyglucose positron emission tomography/computed tomography revealing strong uptake in the left adrenal region with a maximum standardized uptake value of 21.39.
Fig. 3Histopathological findings. (a) H&E staining (×100): section of the adrenocortical adenoma showing solid sheets and nests of acidophilic cells with large and small nuclei, Immunohistochemistry of the adrenocortical adenoma; (b) SF-1 (×100): positive; (c) alpha-inhibin (×100): positive; (d) Ki-67 (×100): low Ki-67-labeling proliferating index (1%–2%). H&E, Hematoxylin and eosin; SF-1, Steroidogenic factor 1.